Showing results (151-160 of 416) with videos related to

Sort By:
Pageof 42
Expert Opinion on Pharmacotherapy|March 12, 2013
PROFILing non-small-cell lung cancer patients for treatment with crizotinib according to anaplastic lymphoma kinase abnormalities: translating science into medicineSara Pilotto, Umberto Peretti, Silvia Novello, et al.
The American Journal of Forensic Medicine and Pathology|January 3, 2018
Cortical Expression of the Polysialylated Isoform of the Neural Cell Adhesion Molecule on Brain Tissue to Recognize Drug-Related Death: An Exploratory AnalysisVito Cirielli, Luca Cima, Chiara Chindemi, et al.
Plos One|June 6, 2015
Prognostic Value of Beta-Tubulin-3 and c-Myc in Muscle Invasive Urothelial Carcinoma of the BladderFrancesco Massari, Emilio Bria, Chiara Ciccarese, et al.
Virchows Archiv : an International Journal of Pathology|June 24, 2021
H3K27me3 immunostaining is diagnostic and prognostic in diffuse gliomas with oligodendroglial or mixed oligoastrocytic morphologySerena Ammendola, Nicolò Caldonazzi, Michele Simbolo, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|October 2, 2007
Loss of chromosome 9p is an independent prognostic factor in patients with clear cell renal cell carcinomaMatteo Brunelli, Albino Eccher, Stefano Gobbo, et al.
Annals of Transplantation|July 25, 2014
Donor kidneys with miliary papillary renal cell neoplasia: the role of the pathologist in determining suitability for transplantationAlbino Eccher, Luigino Boschiero, Francesca Fior, et al.
Prostate Cancer and Prostatic Diseases|August 3, 2026
Prognostic value of cribriform pattern and intraductal carcinoma of the prostate after radical prostatectomy: A systematic review and meta-analysis using contemporary consensus recommendationsFrancesco Ditonno, Alessandro Veccia, Rui M Bernardino, et al.
Pathology|December 23, 2009
Utility of racemase and other immunomarkers in the detection of adenocarcinoma in prostatic tissue damaged by high intensity focused ultrasound therapyDaniela Dalfior, Brett Delahunt, Matteo Brunelli, et al.
Histopathology|December 16, 2011
Classical lobular breast carcinoma consistently lacks topoisomerase-IIα gene amplification: implications for the tailored use of anthracycline-based chemotherapiesEleonora Brunello, Matteo Brunelli, Erminia Manfrin, et al.
European Journal of Cancer (Oxford, England : 1990)|July 31, 2017
Addressing the best treatment for non-clear cell renal cell carcinoma: A meta-analysis of randomised clinical trials comparing VEGFR-TKis versus mTORi-targeted therapiesChiara Ciccarese, Roberto Iacovelli, Matteo Brunelli, et al.
Pageof 42